Published in Acta Reumatol Port on September 03, 2009
Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res (2009) 5.10
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst (2007) 5.10
Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients. Clin Cancer Res (2008) 2.84
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neuro Oncol (2011) 2.13
Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. J Urol (2008) 2.03
The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery. J Urol (2012) 1.65
Identifying rodent hantavirus reservoirs, Brazil. Emerg Infect Dis (2004) 1.58
Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology (2003) 1.57
The Portuguese Society of Rheumatology position paper on the use of biosimilars. Acta Reumatol Port (2014) 1.42
PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. Int J Radiat Oncol Biol Phys (2005) 1.23
Hantavirus pulmonary syndrome in northwestern Argentina: circulation of Laguna Negra virus associated with Calomys callosus. Am J Trop Med Hyg (2004) 1.22
Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma. Clin Genitourin Cancer (2007) 1.19
Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol (2014) 1.07
Leiomyosarcoma of the renal vein: case report and review of the literature. Urol Oncol (2005) 1.02
Evidence that the Agr-like quorum sensing system regulates the toxin production, cytotoxicity and pathogenicity of Clostridium perfringens type C isolate CN3685. Mol Microbiol (2011) 1.01
Children's mental health and family functioning in Rhode Island. Pediatrics (2007) 0.98
Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma. Cancer (2008) 0.97
Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis. Otolaryngol Head Neck Surg (2004) 0.91
[Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]. Acta Reumatol Port (2006) 0.90
Success of root canal therapy in HIV-positive patients. Gen Dent (2006) 0.89
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res Ther (2007) 0.89
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 update. Acta Reumatol Port (2012) 0.87
Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitis. Otolaryngol Head Neck Surg (2005) 0.85
Oral enzastaurin in prostate cancer: a two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic disease. Invest New Drugs (2010) 0.83
[Secondary amyloidosis and systemic lupus erythematosus]. Acta Reumatol Port (2009) 0.82
Theoretical study of excitation energy transfer in DNA photolyase. J Phys Chem B (2008) 0.82
A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer. Invest New Drugs (2013) 0.80
[Budd-Chiari syndrome and severe thrombocytopenia in a patient with Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome]. Acta Reumatol Port (2007) 0.80
The immunological effect of photopheresis in children with newly diagnosed type 1 diabetes. Pediatr Res (2005) 0.80
Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol (2004) 0.79
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 update. Acta Reumatol Port (2010) 0.79
Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin. J Thromb Thrombolysis (2008) 0.78
[Cardiovascular risk profile in a Portuguese cohort of SLE Portuguese patients]. Acta Reumatol Port (2009) 0.78
A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent? Clin Rheumatol (2013) 0.78
[Cyclophosphamide induced amenorrhoea in pre-menopausal women with systemic lupus erythematosus]. Acta Reumatol Port (2008) 0.78
[Health-related quality of life and chronic pain experience in rheumatic diseases]. Acta Reumatol Port (2009) 0.77
Arthritis and X-linked agammaglobulinemia. Acta Reumatol Port (2008) 0.77
Differential immunologic and microRNA effects of 2 dosing regimens of recombinant human granulocyte/macrophage colony stimulating factor. J Immunother (2012) 0.77
Exercise-induced pulmonary hypertension in scleroderma patients: a common finding but with elusive pathophysiology. Echocardiography (2012) 0.76
Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage. Acta Reumatol Port (2010) 0.76
[Demineralised cortical bone allografting in femoral head necrosis]. Acta Reumatol Port (2009) 0.76
2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis. Acta Reumatol Port (2012) 0.76
Triamcinolone acetonide and fluticasone propionate nasal sprays provide comparable relief of seasonal allergic rhinitis symptoms regardless of disease severity. Allergy Asthma Proc (2005) 0.75
[Practical guide for the use of biological agents in rheumatoid arthritis - December 2011 update]. Acta Reumatol Port (2012) 0.75
[Evanescent rash]. Acta Reumatol Port (2008) 0.75
[Primary Sjögren syndrome and inclusion body myositis]. Acta Reumatol Port (2009) 0.75
[Congenital diastasis of pubic symphysis]. Acta Reumatol Port (2009) 0.75
[An unusual case of generalized pain: paramyloidosis simulating fibromyalgia]. Acta Reumatol Port (2009) 0.75
[Nail patella syndrome]. Acta Reumatol Port (2007) 0.75
[Report of an amyopathic dermatomyositis clinical case]. Acta Reumatol Port (2009) 0.75
Evaluation of factors of importance for clinical dementia diagnosis. Dement Geriatr Cogn Disord (2005) 0.75
[Difuse non-Hodgkin lymphoma in a patient with systemic lupus erythematosus]. Acta Reumatol Port (2009) 0.75
[Recommendations for the diagnosis and management of osteoporosis]. Acta Reumatol Port (2007) 0.75
[Rheumatology training in Europe new paradigms recommended by the European Board of Rheumatology]. Acta Reumatol Port (2008) 0.75
[Aortic insufficiency and rheumatoid nodules - a rare occurrence]. Acta Reumatol Port (2010) 0.75
Increased prevalence of allergic sensitisation in rheumatoid arthritis patients treated with anti-TNFalpha. Joint Bone Spine (2009) 0.75
Discriminant Context Information Analysis for Post-Ranking Person Re-Identification. IEEE Trans Image Process (2017) 0.75
[Lofgren syndrome: the relevance of the chest X-ray]. Acta Reumatol Port (2009) 0.75
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update. Acta Reumatol Port (2012) 0.75
[Practical guide for the use of biotechnological therapies in rheumatoid arthritis]. Acta Reumatol Port (2009) 0.75
[Intersticial lung disease as the sole manifestation of antisynthetase syndrome]. Acta Reumatol Port (2009) 0.75
Safety and clinical relief over 1 year with triamcinolone acetonide hydrofluoroalkane-134a nasal aerosol in patients with perennial allergic rhinitis. Allergy Asthma Proc (2006) 0.75
[Acenocoumarol and vasculitis - a rare case]. Acta Reumatol Port (2010) 0.75
[Gorham syndrome, a rare disease...]. Acta Reumatol Port (2010) 0.75
Triamcinolone acetonide and fluticasone propionate aqueous nasal sprays significantly improve nasal airflow in patients with seasonal allergic rhinitis. Allergy Asthma Proc (2004) 0.75